40
Participants
Start Date
October 31, 2015
Primary Completion Date
December 31, 2017
Dabigatranetexilate
After inclusion of the subjects with LA thrombus, they are treated according to the randomization either with Dabigatran (150 mg bid) or Phenprocoumon (INR adjusted once) for the treatment period of 12 months.
Phenprocoumon
After inclusion of the subjects with LA thrombus, they are treated according to the randomization either with Dabigatran (150 mg bid) or Phenprocoumon (INR adjusted once) for the treatment period of 12 months.
RECRUITING
Department of Internal Medicine II, University Hospital Ulm, Ulm
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
University of Ulm
OTHER